604 related articles for article (PubMed ID: 32059726)
1. Direct medical costs of end-stage kidney disease and renal replacement therapy: a cohort study in Guangzhou City, southern China.
Zhang H; Zhang C; Zhu S; Ye H; Zhang D
BMC Health Serv Res; 2020 Feb; 20(1):122. PubMed ID: 32059726
[TBL] [Abstract][Full Text] [Related]
2. Healthcare costs in chronic kidney disease and renal replacement therapy: a population-based cohort study in Sweden.
Eriksson JK; Neovius M; Jacobson SH; Elinder CG; Hylander B
BMJ Open; 2016 Oct; 6(10):e012062. PubMed ID: 27855091
[TBL] [Abstract][Full Text] [Related]
3. Costs of hospitalization for stroke from two urban health insurance claims data in Guangzhou City, southern China.
Zhang H; Yin Y; Zhang C; Zhang D
BMC Health Serv Res; 2019 Sep; 19(1):671. PubMed ID: 31533714
[TBL] [Abstract][Full Text] [Related]
4. Healthcare costs of patients on different renal replacement modalities - Analysis of Dutch health insurance claims data.
Mohnen SM; van Oosten MJM; Los J; Leegte MJH; Jager KJ; Hemmelder MH; Logtenberg SJJ; Stel VS; Hakkaart-van Roijen L; de Wit GA
PLoS One; 2019; 14(8):e0220800. PubMed ID: 31415578
[TBL] [Abstract][Full Text] [Related]
5. Filtering for the best policy: An economic evaluation of policy options for kidney replacement coverage in the Philippines.
Bayani DBS; Almirol BJQ; Uy GDC; Taneo MJS; Danguilan RS; Arakama MI; Lamban AB; de Leon D; Pamugas GEP; Luz AC; Teerawatananon Y
Nephrology (Carlton); 2021 Feb; 26(2):170-177. PubMed ID: 33207027
[TBL] [Abstract][Full Text] [Related]
6. Direct Medical Costs of Parkinson's Disease in Southern China: A Cross-Sectional Study Based on Health Insurance Claims Data in Guangzhou City.
Zhang H; Zhou W; Zhang D
Int J Environ Res Public Health; 2022 Mar; 19(6):. PubMed ID: 35328925
[TBL] [Abstract][Full Text] [Related]
7. Can dialysis patients be accurately identified using healthcare claims data?
Taneja C; Berger A; Inglese GW; Lamerato L; Sloand JA; Wolff GG; Sheehan M; Oster G
Perit Dial Int; 2014; 34(6):643-51. PubMed ID: 24497600
[TBL] [Abstract][Full Text] [Related]
8. Cost analysis of renal replacement therapy by transplant in a system of bundled payment of dialysis.
Rocha MJ; Ferreira S; Martins LS; Almeida M; Dias L; Pedroso S; Henriques AC; Almeida R; Cabrita A
Clin Transplant; 2012; 26(4):529-31. PubMed ID: 22211715
[TBL] [Abstract][Full Text] [Related]
9. Direct medical costs of ischemic heart disease in urban Southern China: a 5-year retrospective analysis of an all-payer health claims database in Guangzhou City.
Xie P; Li X; Guo F; Zhang D; Zhang H
Front Public Health; 2023; 11():1146914. PubMed ID: 37228711
[TBL] [Abstract][Full Text] [Related]
10. Cost comparison of peritoneal dialysis versus hemodialysis in end-stage renal disease.
Berger A; Edelsberg J; Inglese GW; Bhattacharyya SK; Oster G
Am J Manag Care; 2009 Aug; 15(8):509-18. PubMed ID: 19670954
[TBL] [Abstract][Full Text] [Related]
11. Costs of Hospitalization for Dementia in Urban China: Estimates from Two Urban Health Insurance Scheme Claims Data in Guangzhou City.
Zhang H; Zhang D; Yin Y; Zhang C; Huang Y
Int J Environ Res Public Health; 2019 Aug; 16(15):. PubMed ID: 31382609
[No Abstract] [Full Text] [Related]
12. Direct medical costs for patients with schizophrenia: a 4-year cohort study from health insurance claims data in Guangzhou city, Southern China.
Zhang H; Sun Y; Zhang D; Zhang C; Chen G
Int J Ment Health Syst; 2018; 12():72. PubMed ID: 30479658
[TBL] [Abstract][Full Text] [Related]
13. Direct and indirect costs of end-stage renal disease patients in the first and second years after initiation of nocturnal home haemodialysis, hospital haemodialysis and peritoneal dialysis.
Wong CKH; Chen J; Fung SKS; Mok MMY; Cheng YL; Kong I; Lo WK; Lui SL; Chan TM; Lam CLK
Nephrol Dial Transplant; 2019 Sep; 34(9):1565-1576. PubMed ID: 30668781
[TBL] [Abstract][Full Text] [Related]
14. Economic burden and cost-utility analysis of three renal replacement therapies in ESRD patients from Yunnan Province, China.
Wu H; Li Q; Cai Y; Zhang J; Cui W; Zhou Z
Int Urol Nephrol; 2020 Mar; 52(3):573-579. PubMed ID: 32009220
[TBL] [Abstract][Full Text] [Related]
15. Cost-effectiveness of haemodialysis and peritoneal dialysis for patients with end-stage renal disease in Singapore.
Yang F; Lau T; Luo N
Nephrology (Carlton); 2016 Aug; 21(8):669-77. PubMed ID: 26566750
[TBL] [Abstract][Full Text] [Related]
16. Health care costs of peritoneal dialysis technique failure and dialysis modality switching.
Chui BK; Manns B; Pannu N; Dong J; Wiebe N; Jindal K; Klarenbach SW
Am J Kidney Dis; 2013 Jan; 61(1):104-11. PubMed ID: 22901772
[TBL] [Abstract][Full Text] [Related]
17. Lifetime cost-effectiveness analysis of first-line dialysis modalities for patients with end-stage renal disease under peritoneal dialysis first policy.
Wong CKH; Chen J; Fung SKS; Mok M; Cheng YL; Kong I; Lo WK; Lui SL; Chan TM; Lam CLK
BMC Nephrol; 2020 Feb; 21(1):42. PubMed ID: 32019528
[TBL] [Abstract][Full Text] [Related]
18. Economic evaluation of palliative management versus peritoneal dialysis and hemodialysis for end-stage renal disease: evidence for coverage decisions in Thailand.
Teerawattananon Y; Mugford M; Tangcharoensathien V
Value Health; 2007; 10(1):61-72. PubMed ID: 17261117
[TBL] [Abstract][Full Text] [Related]
19. Cost-effectiveness analysis of renal replacement therapy strategies in Guangzhou city, southern China.
Yang F; Liao M; Wang P; Liu Y
BMJ Open; 2021 Feb; 11(2):e039653. PubMed ID: 33550227
[TBL] [Abstract][Full Text] [Related]
20. Cost analysis of renal replacement therapies in Finland.
Salonen T; Reina T; Oksa H; Sintonen H; Pasternack A
Am J Kidney Dis; 2003 Dec; 42(6):1228-38. PubMed ID: 14655195
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
